The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders

Journal of Clinical Psychiatry

Volumn 73, Issue 11, 2012, Pages

  Dakwar, Elias ^a   Mahony, Amy ^a   Pavlicova, Martina ^b   Glass, Andrew ^a   Brooks, Daniel ^a   Mariani, John J ^a   Grabowski, John ^c   Levin, Frances Rudnick ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Department of Biostatistics Columbia College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT ADHD SELF REPORT SCALE VERSION 1.1; ARTICLE; ATTENTION DEFICIT DISORDER; COCAINE DEPENDENCE; CONNERS ADULT ADHD RATING SCALE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DSM-IV; FEMALE; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RELIABILITY; SELF REPORT; SEMI STRUCTURED INTERVIEW; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; WENDER UTAH RATING SCALE;

EID: 84869214770     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m07895     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention (CDC). Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children-United States, 2003 and 2007. MMWR Morb Mortal Wkly Rep. 2010;59(44):1439-1443. PubMed
2. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723. doi:10.176/api.ajp.163.4.716 PubMed (Pubitemid 44464584)
3. Mannuzza S, Klein RG, Bessler A, et al. Adult outcome of hyperactive boys: educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry. 1993;50(7):565-576. doi:10.101/archpsyc.193.018201906707 PubMed (Pubitemid 23203567)
4. Kessler RC, Lane M, Stang PE, et al. The prevalence and workplace costs of adult attention deficit hyperactivity disorder in a large manufacturing firm. Psychol Med. 2009;(1):137-147. PubMed
5. Able SL, Johnston JA, Adler LA, et al. Functional and psychosocial impairment in adults with undiagnosed ADHD. Psychol Med. 2007;37(1):97-107. doi:10.1017/S0329170608713 PubMed (Pubitemid 46043846)
6. Faraone SV, Biederman J, Spencer T, et al. Attention-deficit/ hyperactivity disorder in adults: an overview. Biol Psychiatry. 2000;48(1):9-20. doi:10.1016/S06-323(0)089-1 PubMed (Pubitemid 30407145)
7. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148(5):564-577. PubMed
8. Wilens TE. The nature of the relationship between attention-deficit/ hyperactivity disorder and substance use. J Clin Psychiatry. 2007;68 (suppl 11):4-8. PubMed (Pubitemid 47606855)
9. Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med. 2006;36(2):167-179. doi:10.1017/S0329170506410 PubMed (Pubitemid 43126141)
10. Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry. 1993;34(2):75-82. doi:10.1016/010-40X(93)9050-E PubMed
11. Wise BK, Cuffe SP, Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat. 2001; 21(3):161-165. PubMed (Pubitemid 33109065)
12. Levin FR, Evans SM, Vosburg SK, et al. Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav. 2004;29(9):1875-1782. PubMed
13. Clure C, Brady KT, Saladin ME, et al. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse. 1999;25(3):441-448. PubMed (Pubitemid 29395139)
14. King VL, Brooner RK, Kidorf MS, et al. Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. J Nerv Ment Dis. 1999;187(8):487-495. PubMed (Pubitemid 29422603)
15. Barkley RA, Brown TE. Unrecognized attention-deficit/hyperactivity disorder in adults presenting with other psychiatric disorders. CNS Spectr. 2008;13(11):977-984. PubMed
16. Levin FR, Upadhyaya HP. Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis. J Clin Psychiatry. 2007;68(7):e18. PubMed
17. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry. 1993;150(6):885-890. PubMed (Pubitemid 23156767)
18. Conners CK, Ehrhard D, Sparrow D. CAARS Adult ADHD Rating Scales. New York, NY: MHS; 1999.
19. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256. PubMed (Pubitemid 40259916)
20. Stein MA, Sandoval R, Szumowski E, et al. Psychometric characteristics of the Wender Utah Rating Scale (WURS): reliability and factor structure for men and women. Psychopharmacol Bull. 1995;31(2):425-433. PubMed
21. Murphy K, Barkley RA. Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry. 1996;37(6):393-401. PubMed (Pubitemid 26383062)
22. Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend. 1998;52(1):15-25. PubMed (Pubitemid 28448698)
23. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry. 2003;53(2):112-120. PubMed (Pubitemid 36126473)
24. Kessler RC, Adler LA, Gruber MJ, et al. Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. Int J Methods Psychiatr Res. 2007;16(2):52-65. doi:10.102/mpr.208 PubMed (Pubitemid 46930456)
25. Ramos-Quiroga JA, Daigre C, Valero S, et al. Validation of the Spanish version of the Attention Deficit Hyperactivity Disorder Adult Screening Scale (ASRS v. 1.1): a novel scoring strategy. Rev Neurol. 2009;48(9): 449-452. PubMed
26. Adler LA, Guida F, Irons S, et al. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility. Postgrad Med. 2009;121(5):7-10. PubMed
27. West SL, Mulsow M, Arredondo R. An examination of the psychometric properties of the Attention Deficit Scales for Adults with outpatient substance abusers. Am J Drug Alcohol Abuse. 2007;33(5):755-764. doi:10.1080/0952906075383 PubMed (Pubitemid 47463783)
28. Levin FR. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. J Clin Psychiatry. 2007;68(suppl 11):9-14. PubMed (Pubitemid 47606856)
29. Epstein JN, Kollins SH. Psychometric properties of an adult ADHD diagnostic interview. J Atten Disord. 2006;9(3):504-514. PubMed (Pubitemid 43171143)
30. First MB, Williams JBL, Spitzer RL, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT). New York, NY: Biometric Research, New York State Psychiatric Institute; 2007.
31. Faraone SV, Biederman J, Spencer T, et al. Diagnosing adult attention deficit hyperactivity disorder: are late onset and subthreshold diagnoses valid? Am J Psychiatry. 2006;163(10):1720-1729. doi:10.176/api.ajp.163.10.1720 PubMed (Pubitemid 44522480)
32. Wang PS, Berglund P, Olfson M, et al. Failure and delay in initial treatment contact after first onset of mental disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6): 603-613. doi:10.101/archpsyc.62.6.603 PubMed (Pubitemid 40973435)
33. McGough JJ, Smalley SL, McCracken JT, et al. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry. 2005;162(9):1621-1627. PubMed (Pubitemid 41318230)
34. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attentiondeficit/ hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry. 2000;61(4):244-251. doi:10.408/JCP.v61n0402 PubMed (Pubitemid 30305365)
35. ADHD and Disruptive Behavior Disorders Workgroup; American Psychiatric Association. Rationale for Changes in ADHD in DSM-5. DSM-5 Development Web site. http://www.dsm5.org/ProposedRevision/ Pages/proposedrevision.aspx?rid=383#. Accessibility verified September 26, 2012.
36. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159-165. doi:10.1017/S032917050471X PubMed (Pubitemid 43126140)
37. Kieling C, Kieling RR, Rohde LA, et al. The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry. 2010;167(1):14-16. doi:10.176/api.ajp.209.09060796 PubMed
38. Solanto MV, Marks DJ, Wasserstein J, et al. Diagnosis of ADHD in adults: what is the appropriate DSM-5 symptom threshold for hyperactivity-impulsivity? [published online ahead of print October 5, 2011] J Atten Disord. PubMed
39. Stewart SH, Connors GJ. Screening for alcohol problems: what makes a test effective? Alcohol Res Health. 2004-2005;28(1):5-16. PubMed
40. Polanczyk G, de Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942-948. doi:10.176/api.ajp.164.6.942 PubMed (Pubitemid 46972911)